This protocol is judged by an institutional evaluate board, an impartial team that reviews any clinical trials involving individuals. If a analyze requires a Agenda I drug, when the board approves the protocol as ethical, the scientists should make an application for an investigational new drug (IND) variety through the FDA.Some researchers and org